Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Johnson & Johnson, a leading name in the medical and precision instruments industry, is headquartered in the United States. Founded in 1886, the company has established itself as a pioneer in healthcare, focusing on medical devices, pharmaceuticals, and consumer health products. With a strong presence in North America, Europe, and Asia, Johnson & Johnson operates across various sectors, including surgical instruments and orthopaedic devices.
Renowned for its innovative approach, Johnson & Johnson offers a diverse range of core products, including advanced surgical tools and cutting-edge diagnostic equipment. The company’s commitment to quality and safety has positioned it as a trusted leader in the industry. Notable achievements include significant advancements in minimally invasive surgery and a robust portfolio of patented technologies, solidifying its market position as a frontrunner in healthcare solutions.
+2 vs industry average
Johnson & Johnson’s score of 34 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing has below-average carbon intensity
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Scope 3 accounts for ••• of total emissions.
Johnson & Johnson reported approximately 430,926,000 kg CO2e in Scope 1 and 2 emissions for 2024. This follows 456,871,000 kg CO2e in 2023 and 514,693,000 kg CO2e in 2022 for the same scopes.
The company has set a long-term ambition to achieve net-zero emissions across its entire value chain (all scopes) by 2045. Additionally, Johnson & Johnson aims for net-zero Scope 1 and 2 carbon emissions by 2040. The company has achieved a 26% reduction in its absolute Scope 1 and 2 greenhouse gas emissions since 2021.
Access structured emission data, company specific factors and auditable source documents
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Johnson & Johnson yet.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more